As of April 2026, Humira held approximately ** percent of the adalimumab market share in the United States. On the other hand, Hyrimoz held a market share of ** percent in the same period.Â
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Samsung Bioepis. (April 26, 2026). Adalimumab market share of Humira and its U.S. biosimilar competitors as of April 2026 [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 28, 2026, from /statistics/1538532/humira-vs-biosimilars-market-share-in-the-us/
Samsung Bioepis. "Adalimumab market share of Humira and its U.S. biosimilar competitors as of April 2026." Chart. April 26, 2026. ÌÇÐÄÆƽâ°æ. Accessed July 28, 2026. /statistics/1538532/humira-vs-biosimilars-market-share-in-the-us/
Samsung Bioepis. (2026). Adalimumab market share of Humira and its U.S. biosimilar competitors as of April 2026. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 28, 2026. /statistics/1538532/humira-vs-biosimilars-market-share-in-the-us/
Samsung Bioepis. "Adalimumab Market Share of Humira and Its U.S. Biosimilar Competitors as of April 2026." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 26 Apr 2026, /statistics/1538532/humira-vs-biosimilars-market-share-in-the-us/
Samsung Bioepis, Adalimumab market share of Humira and its U.S. biosimilar competitors as of April 2026 ÌÇÐÄÆƽâ°æ, /statistics/1538532/humira-vs-biosimilars-market-share-in-the-us/ (last visited July 28, 2026)
Adalimumab market share of Humira and its U.S. biosimilar competitors as of April 2026 [Graph], Samsung Bioepis, April 26, 2026. [Online]. Available: /statistics/1538532/humira-vs-biosimilars-market-share-in-the-us/
